In obese Wistar rats with T2DM, exogenous injection of adropin resulted in reduced blood glucose level, improved insulin sensitivity, ameliorated hyperlipidemia, and inhibited levels of inflammatory cytokines [37]. The gene discussed is INS; the disease is type 2 diabetes mellitus.